INSTITUT DE RECHERCHES SERVIER - FR 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 8
As coordinator: 0
As participant: 8
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 3.260.000 0 1
2020 0 64.494.186 0 2
2019 0 27.694.979 0 4
2018 0 18.249.993 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
BAYER5
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG4
JANSSEN PHARMACEUTICA NV4
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN4
PFIZER LIMITED4
TAKEDA PHARMACEUTICALS INTERNATIONAL4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
KATHOLIEKE UNIVERSITEIT LEUVEN3
LEIDS UNIVERSITAIR MEDISCH CENTRUM3
NOVARTIS PHARMA3
UNIVERSITY OF DUNDEE3
ABBVIE INC2
ASTELLAS PHARMA EUROPE BV2
ASTRAZENECA2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
IKTOS2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT2
SANOFIAVENTIS2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
THE UNIVERSITY OF EDINBURGH2
UCB BIOPHARMA2
UNIWERSYTET JAGIELLONSKI2
ACCADEMIA DEL PAZIENTE ESPERTO EUPATI APS1
ACCADEMIA EUROPEA PER LA RICERCA APPLICATA ED IL PERFEZIONAMENTO PROFESSIONALE BOLZANO1
ADERA SAS1
AIBIOPHARMA1
AICURIS ANTIINFECTIVE CURES1
ALMIRALL1
AMGEN RESEARCH1
ARTTIC1
ARTTIC INNOVATION1
ASSOCIAZIONE CITTADINANZATTIVA ONLUS1
ASTRAZENECA AB1
AZIENDA OSPEDALIERA UNIVERSITARIA POLICLINICO DI MODENA1
BAYER AKTIENGESELLSCHAFT1
BILL & MELINDA GATES FOUNDATION1
BIOASCENT DISCOVERY LIMITED1
BIONEER1
BIOSCI CONSULTING BVBA1
BLUEBIRD BIO INC1
BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CENTRE DE REGULACIO GENOMICA1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CENTRUM VOOR INNOVATIE EN STIMULATIE VAN MEDICIJNONTWIKKELING LEUVEN VZW1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
COVANCE LABORATORIES1
DEPARTMENT OF HEALTH1
DIAMOND LIGHT SOURCE LIMITED1
DYNAMIC421
EDELRIS SAS1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
EIDGENOESSISCHES DEPARTEMENT DES INNERN1
ELI LILLY AND COMPANY LIMITED1
ENYO PHARMA1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION1
EUROVACC FOUNDATION1
EXSCIENTIA LIMITED1
F HOFFMANNLA ROCHE1
FUJIFILM CELLULAR DYNAMICS INC1
FUNDACAO D ANNA SOMMER CHAMPALIMAUD E DR CARLOS MONTEZ CHAMPALIMAUD1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSIATRIO LA PAZ1
GEORG SPEYER HAUS CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
GLOBAL HEALTH DRUG DISCOVERY INSTITUTE1
GRUNENTHAL1
H LUNDBECK AS1
HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG1
IMAGINE OPTIC1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE1
INPECO1
INPECO TPM1
INSERM TRANSFERT1
INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUT ZA MEDICINSKA ISTRA IVANJA1
INTELLIGENT IMAGING INNOVATIONS1
JDRF INTERNATIONAL1
KAROLINSKA INSTITUTE1
KUBERMATIC1
KUNGLIGA TEKNISKA HOEGSKOLAN1
LAVISION BIOTEC1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
LUND UNIVERSITY1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MDSOL EUROPE1
MEDICINES FOR MALARIA VENTURE1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MEDIZINISCHE UNIVERSITAT GRAZ1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
MERCALEADS BV1
MERCATORIAL BV1
MERCK SHARP & DOHME CORP1
NOVO NORDISK1
NUVISAN ICB1
NVIDIA SWITZERLAND1
ODYSSEUS DATA SERVICES SRO1
ONTARIO INSTITUTE FOR CANCER RESEARCH1

Constancy:

Total number of partners: 192
Partner loyalty:
Frequent Partner: (> 2 projects): 40
Rare Partner: 152
Frequent / Rare Partner Ratio: 0.26

Project overview:

Start dateProjectacronymrolefundingpartners
2022-01-01FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem FACILITATEparticipant3.260.00029
2020-05-01EUbOPEN: Enabling and Unlocking biology in the OPEN EUbOPENparticipant27.935.00023
2020-04-01Corona Accelerated R&D in Europe CAREparticipant36.559.18643
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2019-10-01ZEbrafish Neuroscience Interdisciplinary Training Hub ZENITHparticipant4.096.01422
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64818
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabparticipant18.249.99320